Edward Wirth, Chief Medical Officer at Asterias Biotherapeutics, Inc. (AST), sold 14,760 shares at $3.58 ($52K) on 2016-09-09, disclosed to the SEC on 2016-09-12.
Scheduled sale ($52k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.50 | 11,581 | $41K | 78.1% |
| 2 | $3.58 | 3,179 | $11K | 21.9% |
| Total | $3.52 avg | 14,760 | $52K | 100% |
| Filing → |
| AST | SELL | 2016-11-21 | $13K | — | Filing → |
| AST | SELL | 2016-10-11 | $28K | — | Filing → |
| AST | SELL | 2015-09-16 | $17K | — | Filing → |